Radiolabeled antibody fragments
Patent
·
OSTI ID:5468404
This patent describes an antibody conjugate of the formula: wherein Ab is the residue of a Fab fragment of a monoclonal antibody. The antibody being one which retains antigen-binding activity following enzymatic removal for the F/sub c/ fragment and reductive cleavage of the disulfide bond joining the heavy chains; -S- is the residue of the free sulfhydryl group of the Fab' fragment; R is a divalent organic linker; and R' is a nontoxic, weakly acidic chelating group capable of forming a chelate with a radionuclide metal ion that is thermodynamically stable under physiological conditions and has a higher stability constant than a chelate of the radionuclide with transferrin in vivo.
- Assignee:
- Mallinckrodt, Inc., St. Louis, MO
- Patent Number(s):
- US 4837003
- Application Number:
- PPN: US 6650127A
- OSTI ID:
- 5468404
- Country of Publication:
- United States
- Language:
- English
Similar Records
In vitro and in vivo targeting of radiolabeled monovalent and divalent haptens with dual specificity monoclonal antibody conjugates: Enhanced divalent hapten affinity for cell-bound antibody conjugate
Selective disulfide reduction for labeling and enhancement of Fab antibody fragments
Higher cytotoxicity of divalent antibody-toxins than monovalent antibody-toxins
Journal Article
·
Tue Aug 01 00:00:00 EDT 1989
· Journal of Nuclear Medicine; (USA)
·
OSTI ID:5262421
Selective disulfide reduction for labeling and enhancement of Fab antibody fragments
Journal Article
·
Thu Nov 24 23:00:00 EST 2016
· Biochemical and Biophysical Research Communications
·
OSTI ID:22696718
Higher cytotoxicity of divalent antibody-toxins than monovalent antibody-toxins
Journal Article
·
Fri Apr 24 00:00:00 EDT 2009
· Biochemical and Biophysical Research Communications
·
OSTI ID:22199660
Related Subjects
550604* -- Medicine-- Unsealed Radionuclides in Therapy-- (1980-)
62 RADIOLOGY AND NUCLEAR MEDICINE
ANTIBODIES
BINDING ENERGY
CHALCOGENIDES
CHELATES
CHEMICAL COMPOSITION
COMPLEXES
DRUGS
ENERGY
IMMUNOLOGY
IMMUNOTHERAPY
IN VIVO
ISOTOPES
LABELLED COMPOUNDS
LABELLING
MEDICINE
MONOCLONAL ANTIBODIES
NUCLEAR MEDICINE
RADIOIMMUNOLOGY
RADIOIMMUNOTHERAPY
RADIOISOTOPES
RADIOLOGY
RADIOPHARMACEUTICALS
RADIOTHERAPY
SULFIDES
SULFUR COMPOUNDS
THERAPY
62 RADIOLOGY AND NUCLEAR MEDICINE
ANTIBODIES
BINDING ENERGY
CHALCOGENIDES
CHELATES
CHEMICAL COMPOSITION
COMPLEXES
DRUGS
ENERGY
IMMUNOLOGY
IMMUNOTHERAPY
IN VIVO
ISOTOPES
LABELLED COMPOUNDS
LABELLING
MEDICINE
MONOCLONAL ANTIBODIES
NUCLEAR MEDICINE
RADIOIMMUNOLOGY
RADIOIMMUNOTHERAPY
RADIOISOTOPES
RADIOLOGY
RADIOPHARMACEUTICALS
RADIOTHERAPY
SULFIDES
SULFUR COMPOUNDS
THERAPY